Page last updated: 2024-11-05

2,4-thiazolidinedione and Pituitary Neoplasms

2,4-thiazolidinedione has been researched along with Pituitary Neoplasms in 2 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.

Research Excerpts

ExcerptRelevanceReference
"Cushing's disease is associated with high morbidity and ultimately mortality."2.42PPAR-gamma in Cushing's disease. ( Heaney, AP, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heaney, AP2
Fernando, M1
Melmed, S1

Reviews

1 review available for 2,4-thiazolidinedione and Pituitary Neoplasms

ArticleYear
PPAR-gamma in Cushing's disease.
    Pituitary, 2004, Volume: 7, Issue:4

    Topics: ACTH-Secreting Pituitary Adenoma; Adrenocorticotropic Hormone; Cushing Syndrome; Humans; Ligands; Ne

2004

Other Studies

1 other study available for 2,4-thiazolidinedione and Pituitary Neoplasms

ArticleYear
PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.
    The Journal of clinical investigation, 2003, Volume: 111, Issue:9

    Topics: Adenoma; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Cell Separation;

2003